Roddy S. O’Connor

11.6k total citations · 4 hit papers
54 papers, 5.8k citations indexed

About

Roddy S. O’Connor is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Roddy S. O’Connor has authored 54 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 24 papers in Immunology and 20 papers in Molecular Biology. Recurrent topics in Roddy S. O’Connor's work include CAR-T cell therapy research (37 papers), Immune Cell Function and Interaction (18 papers) and Viral Infectious Diseases and Gene Expression in Insects (13 papers). Roddy S. O’Connor is often cited by papers focused on CAR-T cell therapy research (37 papers), Immune Cell Function and Interaction (18 papers) and Viral Infectious Diseases and Gene Expression in Insects (13 papers). Roddy S. O’Connor collaborates with scholars based in United States, Iran and United Kingdom. Roddy S. O’Connor's co-authors include Michael C. Milone, Carl H. June, Omkar U. Kawalekar, Saba Ghassemi, Nathaniel W. Snyder, Grace K. Pavlath, John Scholler, Joseph A. Fraietta, Prachi Patel and Ian A. Blair and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Roddy S. O’Connor

54 papers receiving 5.7k citations

Hit Papers

CAR T cell immunotherapy for human cancer 2016 2026 2019 2022 2018 2016 2021 2022 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CAR T cell immunotherapy for human cancer
    2018 2.1k citations Carl H. June, Roddy S. O’Connor et al. profile →
  2. Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
    2016 887 citations Omkar U. Kawalekar, Roddy S. O’Connor et al. Immunity profile →
  3. CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
    2021 243 citations Alba Rodríguez-García, Rachel C. Lynn et al. Nature Communications profile →
  4. Rapid manufacturing of non-activated potent CAR T cells
    2022 184 citations Saba Ghassemi, Joseph S. Durgin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roddy S. O’Connor United States 25 3.7k 2.4k 2.1k 1.4k 887 54 5.8k
Michael Schmitt Germany 43 3.2k 0.9× 2.6k 1.1× 2.6k 1.2× 546 0.4× 845 1.0× 273 7.1k
Christine E. Brown United States 54 5.6k 1.5× 2.6k 1.1× 3.6k 1.8× 2.2k 1.6× 1.5k 1.7× 176 9.5k
Carlos A. Ramos United States 35 4.3k 1.2× 2.0k 0.8× 2.1k 1.0× 1.0k 0.8× 1.5k 1.6× 107 6.2k
Avery D. Posey United States 26 3.0k 0.8× 1.4k 0.6× 1.5k 0.7× 1.1k 0.8× 868 1.0× 48 3.9k
Rosandra N. Kaplan United States 22 3.5k 0.9× 1.9k 0.8× 2.2k 1.0× 890 0.6× 450 0.5× 51 5.7k
Saba Ghassemi United States 17 2.3k 0.6× 1.3k 0.5× 1.3k 0.6× 1.1k 0.8× 517 0.6× 42 3.9k
Nabil Ahmed United States 27 4.1k 1.1× 1.8k 0.7× 1.3k 0.6× 1.4k 1.0× 1.1k 1.3× 90 5.7k
Gregory L. Beatty United States 43 8.4k 2.3× 5.4k 2.2× 3.0k 1.5× 1.3k 0.9× 935 1.1× 102 11.6k
Christopher A. Klebanoff United States 41 7.9k 2.2× 7.9k 3.2× 3.0k 1.5× 1.1k 0.8× 1.7k 2.0× 77 11.7k
Naoto Hirano Canada 31 1.9k 0.5× 2.1k 0.9× 1.7k 0.8× 293 0.2× 525 0.6× 87 4.4k

Countries citing papers authored by Roddy S. O’Connor

Since Specialization
Citations

This map shows the geographic impact of Roddy S. O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roddy S. O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roddy S. O’Connor more than expected).

Fields of papers citing papers by Roddy S. O’Connor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roddy S. O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roddy S. O’Connor. The network helps show where Roddy S. O’Connor may publish in the future.

Co-authorship network of co-authors of Roddy S. O’Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Roddy S. O’Connor. A scholar is included among the top collaborators of Roddy S. O’Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roddy S. O’Connor. Roddy S. O’Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Veliz, Kimberly, Feng Shen, Olga Shestova, et al.. (2024). Deletion of CD38 enhances CD19 chimeric antigen receptor T cell function. SHILAP Revista de lepidopterología. 32(2). 200819–200819. 6 indexed citations
2.
Ebrahimi, Ammar, et al.. (2023). Current Status and Challenges of Vaccination Therapy for Glioblastoma. Molecular Cancer Therapeutics. 22(4). 435–446. 15 indexed citations
3.
Xiao, Yansen, Omar Johnson, Roddy S. O’Connor, et al.. (2023). Sequential Exposure to IL21 and IL15 During Human Natural Killer Cell Expansion Optimizes Yield and Function. Cancer Immunology Research. 11(11). 1524–1537. 16 indexed citations
4.
Tang, Yan, Wei Liu, Omar Johnson, et al.. (2023). Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy. Blood. 143(2). 139–151. 9 indexed citations
5.
O’Connor, Roddy S.. (2023). Checkmate: Metabolic flexibility with a STING in its tail. Science Advances. 9(49). eadm6816–eadm6816. 3 indexed citations
6.
Durgin, Joseph S., Radhika Thokala, Lexus R. Johnson, et al.. (2021). Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase. Molecular Therapy. 30(3). 1201–1214. 21 indexed citations
7.
Rodríguez-García, Alba, Rachel C. Lynn, Mathilde Poussin, et al.. (2021). CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy. Nature Communications. 12(1). 877–877. 243 indexed citations breakdown →
8.
Durgin, Joseph S., Fraser Henderson, MacLean P. Nasrallah, et al.. (2021). Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma. Frontiers in Oncology. 11. 669071–669071. 54 indexed citations
9.
Huarte, Eduardo, Roddy S. O’Connor, Michael T. Peel, et al.. (2020). Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy. Clinical Cancer Research. 26(23). 6299–6309. 67 indexed citations
10.
Varner, Erika L., Sophie Trefely, David Bartee, et al.. (2020). Quantification of lactoyl-CoA (lactyl-CoA) by liquid chromatography mass spectrometry in mammalian cells and tissues. Open Biology. 10(9). 200187–200187. 100 indexed citations
11.
Ghassemi, Saba, Francisco J. Martinez-Becerra, Аlyssa M. Master, et al.. (2020). Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media Design. Molecular Therapy — Methods & Clinical Development. 18. 595–606. 52 indexed citations
12.
O’Connor, Roddy S. & Michael C. Milone. (2019). Testing the Specificity of Compounds Designed to Inhibit CPT1A in T Cells. Methods in molecular biology. 2097. 83–90. 2 indexed citations
13.
Sellmyer, Mark A., Sarah A. Richman, Catherine Hou, et al.. (2019). Imaging CAR T Cell Trafficking with eDHFR as a PET Reporter Gene. Molecular Therapy. 28(1). 42–51. 76 indexed citations
14.
Ghassemi, Saba, Selene Nuñez-Cruz, Roddy S. O’Connor, et al.. (2018). Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells. Cancer Immunology Research. 6(9). 1100–1109. 212 indexed citations
15.
O’Connor, Roddy S., Lili Guo, Saba Ghassemi, et al.. (2018). The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations. Scientific Reports. 8(1). 6289–6289. 126 indexed citations
16.
Hippen, Keli L., Roddy S. O’Connor, Asim Saha, et al.. (2017). In Vitro Induction of Human Regulatory T Cells Using Conditions of Low Tryptophan Plus Kynurenines. American Journal of Transplantation. 17(12). 3098–3113. 24 indexed citations
17.
Kawalekar, Omkar U., Roddy S. O’Connor, Joseph A. Fraietta, et al.. (2016). Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells. Immunity. 44(2). 380–390. 887 indexed citations breakdown →
18.
O’Connor, Roddy S., et al.. (2012). Substrate rigidity regulates human T cell activation and proliferation (52.9). The Journal of Immunology. 188(1_Supplement). 52.9–52.9. 1 indexed citations
19.
Duan, Fenghai, Lynette M. Smith, Roddy S. O’Connor, et al.. (2011). Genomic and Clinical Analysis of Amplification of the 13q31 Chromosomal Region in Alveolar Rhabdomyosarcoma: A Report from the Children's Oncology Group. Clinical Cancer Research. 17(6). 1463–1473. 50 indexed citations
20.
Mitchell, Patrick O., et al.. (2005). Sca-1 negatively regulates proliferation and differentiation of muscle cells. Developmental Biology. 283(1). 240–252. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Schmitt Breakdown of academic impact, for papers by Christine E. Brown Breakdown of academic impact, for papers by Carlos A. Ramos Breakdown of academic impact, for papers by Avery D. Posey Breakdown of academic impact, for papers by Rosandra N. Kaplan Breakdown of academic impact, for papers by Saba Ghassemi Breakdown of academic impact, for papers by Nabil Ahmed Breakdown of academic impact, for papers by Gregory L. Beatty Breakdown of academic impact, for papers by Christopher A. Klebanoff Breakdown of academic impact, for papers by Naoto Hirano
Rankless by CCL
2026